查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1590761

製剂开发外包市场：按服务、剂型和应用分类 - 2025-2030 年全球预测

Formulation Development Outsourcing Market by Service (Formulation Optimization, Pre-formulation Services), Dosage Form (Injectable, Oral, Topical), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药品开发外包市场规模为400.1亿美元，预计2024年将达437.6亿美元，复合年增长率为9.85%，预计到2030年将达到772.6亿美元。

製剂开发外包涉及与专业製药公司签订合同，以创新和优化对药物开发过程至关重要的製剂。这种需求源自于对专业知识的需求，以克服复杂的配方挑战、优化生物有效性、确保稳定性并满足监管要求，同时缩短上市时间。应用涵盖癌症、神经病学和感染疾病等多个治疗领域，最终用途主要在製药和生物技术行业。市场开拓受到对具有成本效益的药物开发的需求不断增长、复杂的生物药物分子的增加以及缺乏内部资源的中小型生物技术公司的激增的影响。扩大服务范围存在商机，包括先进的药物输送系统、个人化医疗接触点以及使用数位技术增强的配方流程。对公司的建议包括投资人工智慧和机器学习等技术平台，以提高预测制定和流程效率，并建立策略伙伴关係以加强服务组合。

主要市场统计
基准年[2023] 400.1亿美元
预测年份 [2024] 437.6亿美元
预测年份 [2030] 772.6亿美元
复合年增长率（%） 9.85%

然而，这个市场面临挑战，包括严格的监管环境、智慧财产权问题和高昂的技术实施成本。此外，还存在来自大公司内部开发能力的竞争压力以及外包模式固有的品管问题的风险。推动成长的创新领域包括用于永续配方的生物分解性聚合物、用于靶向药物传输的奈米配方以及采用连续製造工艺。对市场情势的了解表明，由于快速的技术进步和联合研究，市场是动态的且高度发展的。随着公司寻求差异化，专注于创建满足各种治疗方法和客户需求的全面且灵活的服务解决方案非常重要。与学术研究机构的合作是获取新调查方法和保持领先新趋势的强大优势。

市场动态：揭示快速发展的製剂开发外包市场的关键市场洞察

供需的动态交互作用正在改变药物开发外包市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 由于慢性病和感染疾病的沉重负担，对新药的需求不断增加
    • 许多注意力集中在开发难溶性化合物以提高生物有效性度。
    • 全球临床试验快速增加
  • 市场限制因素
    • 药物研发外包高成本
  • 市场机会
    • 增加研发费用改善药品开发外包服务
    • 製剂开发新技术的开发
  • 市场挑战
    • 与製剂开发外包相关的品管复杂性

波特五力：驾驭製剂开发外包市场的策略工具

波特的五力架构是了解药物开发外包市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药物开发外包市场的外部影响

外部宏观环境因素在塑造药物开发外包市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解製剂开发外包市场的竞争状况

药品开发外包市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵製剂开发外包市场供应商绩效评估

FPNV定位矩阵是评估製剂开发外包市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製製剂开发外包市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对药物开发外包市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于慢性病和感染疾病的沉重负担，对新药的需求不断增加。
      • 专注于开发难溶性化合物以提高生物有效性
      • 全球临床研究数量迅速增加
    • 抑制因素
      • 外包药物研发的成本很高。
    • 机会
      • 增加研发费用改善药品开发外包服务
      • 製剂开发新技术的开发
    • 任务
      • 与製剂开发外包相关的品管复杂性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药品开发外包市场：依服务分类

  • 处方优化
    • 第一阶段
    • 第二阶段
    • 第三阶段
    • 第四阶段
  • 预先处方服务
    • 分析服务
    • 探索性和临床前服务

第七章以剂型分類的製剂开发外包市场

  • 可注射的
  • 口服
  • 话题

第八章 药品开发外包市场：依应用分类

  • 心血管
  • 遗传疾病
  • 感染疾病
  • 神经病学
  • 肿瘤学
  • 呼吸系统

第九章 北美和南美製剂开发外包市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太製剂开发外包市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲製剂开发外包市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Aizant Drug Research Solutions Private Limited
  • Cambrex Corporation
  • Catalent Inc.
  • Emergent Biosolutions Inc.
  • Eurofins Scientific SE
  • Intertek Group PLC
  • Jubilant Pharmova Limited
  • Lonza Group AG
  • Piramal Group
  • Quotient Sciences Limited
  • Recipharm AB
  • Samsung Biologics Co., Ltd.
  • SGS SA
  • Siegfried AG
  • Syngene International Limited
Product Code: MRR-0D217D5AE50B

The Formulation Development Outsourcing Market was valued at USD 40.01 billion in 2023, expected to reach USD 43.76 billion in 2024, and is projected to grow at a CAGR of 9.85%, to USD 77.26 billion by 2030.

Formulation Development Outsourcing involves contracting specialized pharmaceutical companies to innovate and optimize formulations for drug products, which is integral to the drug development process. The necessity arises from the need for expertise in navigating complex formulation challenges, optimizing bioavailability, ensuring stability, and meeting regulatory requirements, all while accelerating time to market. Application spans across multiple therapeutic areas, including oncology, neurology, and infectious diseases, with end-use primarily in pharmaceutical and biotechnology industries. Market growth is influenced by the rising demand for cost-effective drug development, the increase in complex and biological drug molecules, and the surge of small to medium-sized biotech firms lacking internal resources. Opportunities lie in expanding service offerings to include advanced drug delivery systems, personalized medicine touchpoints, and leveraging digital technologies for enhanced formulation processes. Recommendations for businesses include investing in technology platforms like AI and machine learning for predictive formulation and enhanced process efficiencies, and forming strategic partnerships to enhance service portfolios.

KEY MARKET STATISTICS
Base Year [2023] USD 40.01 billion
Estimated Year [2024] USD 43.76 billion
Forecast Year [2030] USD 77.26 billion
CAGR (%) 9.85%

However, this market faces challenges such as stringent regulatory landscapes, IP concerns, and the high cost of technology adoption. Additionally, there is a competitive pressure from in-house development capabilities of larger firms and the risk of quality control issues inherent to outsourcing models. To foster growth, areas of innovation include biodegradable polymers for sustainable formulations, nanoformulation for targeted drug delivery, and adoption of continuous manufacturing processes. Insight into the market's nature reveals a dynamic and highly evolving landscape driven by rapid technological advancements and collaborations. As companies strive for differentiation, an emphasis on building comprehensive and flexible service solutions that meet diverse therapeutic and client needs will be critical. Engaging in collaboration with academic research institutions can provide a significant edge in accessing novel formulation methodologies and staying ahead of emerging trends.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Formulation Development Outsourcing Market

The Formulation Development Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for new drugs owing to the high burden of chronic and infectious diseases
    • Huge focus on developing poorly water-soluble compounds to improve bioavailability
    • Rapidly growing number of clinical studies globally
  • Market Restraints
    • High cost of formulation development outsourcing
  • Market Opportunities
    • Increasing R&D spending to improve the formulation development outsourcing services
    • Development of new technologies for formulation development
  • Market Challenges
    • Quality control complexities associated with formulation development outsourcing

Porter's Five Forces: A Strategic Tool for Navigating the Formulation Development Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Formulation Development Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Formulation Development Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Formulation Development Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Formulation Development Outsourcing Market

A detailed market share analysis in the Formulation Development Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Formulation Development Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Formulation Development Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Formulation Development Outsourcing Market

A strategic analysis of the Formulation Development Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Formulation Development Outsourcing Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aizant Drug Research Solutions Private Limited, Cambrex Corporation, Catalent Inc., Emergent Biosolutions Inc., Eurofins Scientific SE, Intertek Group PLC, Jubilant Pharmova Limited, Lonza Group AG, Piramal Group, Quotient Sciences Limited, Recipharm AB, Samsung Biologics Co., Ltd., SGS S.A., Siegfried AG, and Syngene International Limited.

Market Segmentation & Coverage

This research report categorizes the Formulation Development Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Formulation Optimization and Pre-formulation Services. The Formulation Optimization is further studied across Phase I, Phase II, Phase III, and Phase IV. The Pre-formulation Services is further studied across Analytical Services and Discovery & Preclinical Services.
  • Based on Dosage Form, market is studied across Injectable, Oral, and Topical.
  • Based on Application, market is studied across Cardiovascular, Genetic Disorders, Infectious Diseases, Neurology, Oncology, and Respiratory.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for new drugs owing to the high burden of chronic and infectious diseases
      • 5.1.1.2. Huge focus on developing poorly water-soluble compounds to improve bioavailability
      • 5.1.1.3. Rapidly growing number of clinical studies globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of formulation development outsourcing
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing R&D spending to improve the formulation development outsourcing services
      • 5.1.3.2. Development of new technologies for formulation development
    • 5.1.4. Challenges
      • 5.1.4.1. Quality control complexities associated with formulation development outsourcing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Formulation Development Outsourcing Market, by Service

  • 6.1. Introduction
  • 6.2. Formulation Optimization
    • 6.2.1. Phase I
    • 6.2.2. Phase II
    • 6.2.3. Phase III
    • 6.2.4. Phase IV
  • 6.3. Pre-formulation Services
    • 6.3.1. Analytical Services
    • 6.3.2. Discovery & Preclinical Services

7. Formulation Development Outsourcing Market, by Dosage Form

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Formulation Development Outsourcing Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular
  • 8.3. Genetic Disorders
  • 8.4. Infectious Diseases
  • 8.5. Neurology
  • 8.6. Oncology
  • 8.7. Respiratory

9. Americas Formulation Development Outsourcing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Formulation Development Outsourcing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Formulation Development Outsourcing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Aizant Drug Research Solutions Private Limited
  • 3. Cambrex Corporation
  • 4. Catalent Inc.
  • 5. Emergent Biosolutions Inc.
  • 6. Eurofins Scientific SE
  • 7. Intertek Group PLC
  • 8. Jubilant Pharmova Limited
  • 9. Lonza Group AG
  • 10. Piramal Group
  • 11. Quotient Sciences Limited
  • 12. Recipharm AB
  • 13. Samsung Biologics Co., Ltd.
  • 14. SGS S.A.
  • 15. Siegfried AG
  • 16. Syngene International Limited

LIST OF FIGURES

  • FIGURE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. FORMULATION DEVELOPMENT OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. FORMULATION DEVELOPMENT OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FORMULATION DEVELOPMENT OUTSOURCING MARKET DYNAMICS
  • TABLE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DISCOVERY & PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. FORMULATION DEVELOPMENT OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. FORMULATION DEVELOPMENT OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023